Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
369.96
-0.95 (-0.26%)
At close: Jan 13, 2026, 4:00 PM EST
370.00
+0.04 (0.01%)
After-hours: Jan 13, 2026, 6:59 PM EST
Alnylam Pharmaceuticals Analyst Ratings
Total Analysts
27
Consensus Rating
Strong Buy
Price Target
$488.08
Upside
+31.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $530 → $529 | Strong Buy | Maintains | $530 → $529 | +42.99% | Jan 12, 2026 |
| Needham | Needham | Strong Buy Maintains $520 → $529 | Strong Buy | Maintains | $520 → $529 | +42.99% | Jan 12, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $535 → $530 | Strong Buy | Maintains | $535 → $530 | +43.26% | Jan 8, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $370 → $351 | Hold | Maintains | $370 → $351 | -5.12% | Dec 15, 2025 |
| Stifel | Stifel | Strong Buy Maintains $495 → $508 | Strong Buy | Maintains | $495 → $508 | +37.31% | Dec 11, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $395 → $479 | Hold | Maintains | $395 → $479 | +29.47% | Nov 11, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $449 → $489 | Buy | Reiterates | $449 → $489 | +32.18% | Oct 31, 2025 |
| Barclays | Barclays | Buy Maintains $460 → $527 | Buy | Maintains | $460 → $527 | +42.45% | Oct 31, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $550 → $549 | Strong Buy | Maintains | $550 → $549 | +48.39% | Oct 30, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $459 → $535 | Strong Buy | Maintains | $459 → $535 | +44.61% | Oct 17, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $475 → $473 | Buy | Maintains | $475 → $473 | +27.85% | Oct 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $570 | Strong Buy | Reiterates | $570 | +54.07% | Oct 10, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $405 → $475 | Hold | Maintains | $405 → $475 | +28.39% | Oct 6, 2025 |
| Stifel | Stifel | Strong Buy Maintains $441 → $495 | Strong Buy | Maintains | $441 → $495 | +33.80% | Oct 6, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $435 → $500 | Buy | Maintains | $435 → $500 | +35.15% | Sep 19, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $453 → $520 | Strong Buy | Maintains | $453 → $520 | +40.56% | Sep 17, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.